Document is current
Any future updates will be listed below
-
Authors
Fukumitsu, Masafumi
Ariyasu, Ryo
Ishiyama, Mitsutomi
Mochizuki, Toshiaki
Takeda, Koichi
Ono, Makiko
Oyakawa, Takuya
Ebihara, Aya
Nishizawa, Aya
Tomomatsu, Junichi
Kogawa, Takahiro
Kitano, Shigehisa
Shiga, Taro https://orcid.org/0000-0003-4205-7534
- License Information
-
More Information
Article History
Received: 27 September 2022
Accepted: 5 December 2022
First Online: 13 December 2022
Declarations
:
: Dr. Makiko Ono receives research funding from Pfizer and Eisai. Dr. Junichi Tomomatsu is an occupational health physician at Eisai. Dr. Takahiro Kogawa receives research funding from Daiichi-Sankyo and Eli-Lily. Dr. Shigehisa Kitano has advisory roles at ImmuniT Research and United Immunity, and received honoraria from Astra Zeneca, Pfizer, MSD, Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb, and Merck Biopharma Co., Ltd. In addition, Dr Shigehisa Kitano receives research funding from Astra Zeneca, Pfizer, Boehringer Ingelheim, MSD, Eisai, Astellas, Ono Pharmaceutical Co., Ltd., Takara Bio Inc., Daiichi-Sankyo, Chugai, Pfizer, and Incyte. Dr. Taro Shiga received lecture fees from Daiichi-Sankyo and Bayer.
